scholarly journals Influenza in patients with cancer after 2009 pandemic AH1N1: An 8‐year follow‐up study in Mexico

2019 ◽  
Vol 14 (2) ◽  
pp. 196-203 ◽  
Author(s):  
Diego Ángeles‐Sistac ◽  
Alexandra Martin‐Onraet ◽  
Patricia Cornejo‐Juárez ◽  
Patricia Volkow ◽  
Carolina Pérez‐Jimenez ◽  
...  
Keyword(s):  
Patients With Cancer ◽  
Follow Up Study

Cognitive variables associated with depressive and anxiety symptoms in patients with cancer: A five‐year follow‐up study

2021 ◽  
Author(s):  
Amador Priede ◽  
Noelia Rodríguez‐Pérez ◽  
Fernando Hoyuela ◽  
Patricia Cordero‐Andrés ◽  
Olga Umaran‐Alfageme ◽  
...  
Keyword(s):  
Anxiety Symptoms ◽  
Cognitive Variables ◽  
Patients With Cancer ◽  
Follow Up Study

scholarly journals Reply to Course and predictors of posttraumatic stress disorder in a cohort of psychologically distressed patients with cancer: A 4-year follow-up study-methodological and statistical issues

Cancer ◽  
2018 ◽  
Vol 124 (11) ◽  
pp. 2457-2457 ◽  
Author(s):  
Caryn Mei Hsien Chan ◽  
Chong Guan Ng ◽  
Aishah Taib ◽  
Lei Hum Wee ◽  
Edward Krupat ◽  
...  
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Posttraumatic Stress ◽  
Stress Disorder ◽  
Patients With Cancer ◽  
Follow Up Study ◽  
Statistical Issues

Analysis of the efficacy and safety of naloxegol administered to patients with cancer and opioid-induced constipation with laxative-inadequate response: A real-world 12 months of follow-up study.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. e24155-e24155
Author(s):  
Manuel Cobo Dols ◽  
Carmen Beato ◽  
Luis Cabezon-Gutierrez ◽  
Rodolfo Chicas Sett ◽  
Isabel Blancas ◽  
...  
Keyword(s):  
Real World ◽  
Pain Control ◽  
Adverse Reactions ◽  
Response To Treatment ◽  
Inadequate Response ◽  
Efficacy And Safety ◽  
Real World Data ◽  
Patients With Cancer ◽  
Follow Up Study

e24155 Background: Naloxegol is a peripherally acting, µ-opioid receptor antagonist for treatment of opioid-induced constipation (OIC). The main objective of this study was to analyze the efficacy and safety of naloxegol in patients with cancer in a real-world 12-month follow-up study. Methods: An observational prospective study was conducted in 16 Spanish centers. Patients older than 18 years, with active oncological disease who were under treatment with opioids for pain control and Karnofsky ≥ 50 were selected. OIC with inadequate response to treatment with laxative (s) was the main diagnostic. All the patients received treatment with naloxegol according to clinical criteria. Efficacy was measured by the response rate and symptoms evolution measured by means of PAC-SYM questionnaire. Intensity of pain was measured by a 0-10-point visual analogue scale (VAS). Intent to treat last observation carried forward was applied. Results: A total of 126 patients were included in the study. About 58.7% were men, with a mean age of 61.5 years (34-89). Lung cancer was observed in 35.7%, breast cancer in 16.7%, 10.3% digestive cancer and 8.7% had prostate cancer. About 67.5% had metastases. Naloxegol at doses of 25 mg/day was administered to 88.1% and with concomitant laxatives in 48.4%. At 12 months, 77.8% of the patients were responders to naloxegol treatment: 78.6% at doses of 12.5 mg/day, and 78.4% with 25 mg/day. Furthermore, response was observed in 78.5% of patients without concomitant laxative treatment and 77% of patients with any concomitant laxative. PAC-SYM total score and all the dimensions improved from baseline (p < 0.0001). VAS pain intensity was reduced and controlled from baseline onwards (Baseline-12 months: 4.6 to 3.6, p < 0.001). A total of 28 adverse reactions mainly gastrointestinal were observed in 15.1% of the patients (19/126), 75% (21) mild, 17.9% (5) moderate and 7.1% (2) severe. Most adverse reactions (67.9%) were observed the first 15 days of treatment with naloxegol. Conclusions: The results of this first real-world-data study in patients with cancer confirm the long-term efficacy of naloxegol for the treatment of OIC in this group of patients. Naloxegol is safe and well tolerated in patients with cancer while maintaining pain control.

Risk of coronary heart disease in patients with cancer: A nationwide follow-up study from Sweden

2012 ◽  
Vol 48 (1) ◽  
pp. 121-128 ◽  
Author(s):  
Bengt Zöller ◽  
Jianguang Ji ◽  
Jan Sundquist ◽  
Kristina Sundquist
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Patients With Cancer ◽  
Follow Up Study

Risk of haemorrhagic and ischaemic stroke in patients with cancer: A nationwide follow-up study from Sweden

2012 ◽  
Vol 48 (12) ◽  
pp. 1875-1883 ◽  
Author(s):  
Bengt Zöller ◽  
Jianguang Ji ◽  
Jan Sundquist ◽  
Kristina Sundquist
Keyword(s):  
Ischaemic Stroke ◽  
Patients With Cancer ◽  
Follow Up Study

The impact of colorectal surgery on health-related quality of life in older functionally dependent patients with cancer – A longitudinal follow-up study

2019 ◽  
Vol 10 (5) ◽  
pp. 724-732 ◽  
Author(s):  
Esteban T.D. Souwer ◽  
Simone Oerlemans ◽  
Lonneke V. van de Poll-Franse ◽  
Felice N. van Erning ◽  
Frederiek van den Bos ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Colorectal Surgery ◽  
Health Related Quality ◽  
Patients With Cancer ◽  
Follow Up Study ◽  
Related Quality ◽  
Health Related ◽  
The Impact

Impact of comprehensive geriatric assessment on short-term mortality in older patients with cancer—a follow-up study

2019 ◽  
Vol 116 ◽  
pp. 27-34 ◽  
Author(s):  
Marianne Ørum ◽  
Kenneth Jensen ◽  
Merete Gregersen ◽  
Peter Meldgaard ◽  
Else Marie Damsgaard
Keyword(s):  
Geriatric Assessment ◽  
Comprehensive Geriatric Assessment ◽  
Older Patients ◽  
Short Term ◽  
Patients With Cancer ◽  
Follow Up Study ◽  
Short Term Mortality

scholarly journals Analysis of the efficacy of naloxegol in a real-world 12 weeks of follow-up study, in patients with cancer and opioid-induced constipation with laxative-inadequate response

2019 ◽  
Vol 30 ◽  
pp. v740
Author(s):  
M. Cobo Dols ◽  
M.D.C. Beato Zambrano ◽  
L. Cabezón Gutiérrez ◽  
R. Chicas Sett ◽  
I. Blancas ◽  
...  
Keyword(s):  
Real World ◽  
Inadequate Response ◽  
Patients With Cancer ◽  
Follow Up Study

Fatigue and Physical Activity in Older Patients With Cancer: A Six-Month Follow-Up Study

2009 ◽  
Vol 36 (2) ◽  
pp. 194-202 ◽  
Author(s):  
Marian Luctkar-Flude ◽  
Dianne Groll ◽  
Kirsten Woodend ◽  
Joan Tranmer
Keyword(s):  
Physical Activity ◽  
Older Patients ◽  
Patients With Cancer ◽  
Follow Up Study
Sign in / Sign up

Export Citation Format

Share Document